Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.

Bouter, Yvonne; Noguerola, Jose Socrates Lopez; Tucholla, Petra; Crespi, Gabriela A N; Parker, Michael W; Wiltfang, Jens; Miles, Luke A; Bayer, Thomas A

Bouter, Yvonne; Noguerola, Jose Socrates Lopez; Tucholla, Petra; Crespi, Gabriela A N; Parker, Michael W; Wiltfang, Jens; Miles, Luke A; Bayer, Thomas A.

Afiliación

Bouter Y; University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Division of Molecular Psychiatry, Göttingen, Germany.
Noguerola JSL; University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Division of Molecular Psychiatry, Göttingen, Germany.
Tucholla P; University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Division of Molecular Psychiatry, Göttingen, Germany.
Crespi GAN; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
Parker MW; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.
Wiltfang J; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia.
Miles LA; University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Göttingen, Germany.
Bayer TA; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia.

Acta Neuropathol ; 147(1): 59, 2024 Mar 25.

Article en En | MEDLINE | ID: mdl-38526686

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Acta Neuropathol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google